• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mechanisms and Efficacy of Traditional Chinese Medicine in Heart Failure.中药治疗心力衰竭的机制与疗效
Front Pharmacol. 2022 Feb 24;13:810587. doi: 10.3389/fphar.2022.810587. eCollection 2022.
2
Traditional Chinese medicine enhances myocardial metabolism during heart failure.中医在心力衰竭期间增强心肌代谢。
Biomed Pharmacother. 2022 Feb;146:112538. doi: 10.1016/j.biopha.2021.112538. Epub 2021 Dec 15.
3
Study protocol: Traditional Chinese Medicine (TCM) syndrome differentiation for heart failure patients and its implication for long-term therapeutic outcomes of the Qiliqiangxin capsules.研究方案:心力衰竭患者的中医证候辨证及其对芪苈强心胶囊长期治疗效果的影响
Chin Med. 2021 Oct 16;16(1):103. doi: 10.1186/s13020-021-00515-1.
4
Natural products from traditional Chinese medicine for the prevention and treatment of heart failure: progress and perspectives.中药天然产物防治心力衰竭的研究进展与展望。
Rev Cardiovasc Med. 2022 Feb 12;23(2):60. doi: 10.31083/j.rcm2302060.
5
Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study.中药在我国西医院治疗急性心力衰竭中的应用:来自中国心力衰竭前瞻性研究(China PEACE)的分析。
J Am Heart Assoc. 2019 Aug 6;8(15):e012776. doi: 10.1161/JAHA.119.012776. Epub 2019 Jul 31.
6
Validation of a new simple scale to measure symptoms in heart failure from traditional Chinese medicine view: a cross-sectional questionnaire study.从中医角度验证一种用于测量心力衰竭症状的新型简易量表:一项横断面问卷调查研究
BMC Complement Altern Med. 2016 Sep 2;16(1):342. doi: 10.1186/s12906-016-1306-7.
7
Traditional Chinese Medicine Targeting Heat Shock Proteins as Therapeutic Strategy for Heart Failure.以热休克蛋白为靶点的中医药治疗心力衰竭策略
Front Pharmacol. 2022 Jan 18;12:814243. doi: 10.3389/fphar.2021.814243. eCollection 2021.
8
Improved medical expenditure and survival with integration of traditional Chinese medicine treatment in patients with heart failure: A nationwide population-based cohort study.心力衰竭患者采用中西医结合治疗可改善医疗支出并提高生存率:一项基于全国人口的队列研究。
Oncotarget. 2017 Aug 8;8(52):90465-90476. doi: 10.18632/oncotarget.20063. eCollection 2017 Oct 27.
9
Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF).芪参益气滴丸对缺血性心力衰竭的补充治疗的临床评估:一项随机、双盲、多中心、安慰剂对照试验的研究方案(CACT-IHF)。
Trials. 2013 May 14;14:138. doi: 10.1186/1745-6215-14-138.
10
Study on the evaluation of the clinical effects of traditional chinese medicine in heart failure by complex intervention: protocol of SECETCM-HF.复杂干预措施下中医药治疗心力衰竭临床效果评价研究:SECETCM-HF 方案。
Trials. 2009 Dec 24;10:122. doi: 10.1186/1745-6215-10-122.

引用本文的文献

1
Cardiac energy metabolic disorder and gut microbiota imbalance: a study on the therapeutic potential of Shenfu Injection in rats with heart failure.心脏能量代谢紊乱与肠道微生物群失衡:参附注射液对心力衰竭大鼠治疗潜力的研究
Front Microbiol. 2025 Feb 25;16:1509548. doi: 10.3389/fmicb.2025.1509548. eCollection 2025.
2
Traditional Chinese medicine as a protective strategy against chemotherapy-induced cardiotoxicity: An overview of the literature.中药作为化疗所致心脏毒性的一种保护策略:文献综述
J Tradit Complement Med. 2024 Jun 22;15(2):107-118. doi: 10.1016/j.jtcme.2024.06.010. eCollection 2025 Mar.
3
Active ingredients of traditional Chinese medicine inhibit NOD-like receptor protein 3 inflammasome: a novel strategy for preventing and treating heart failure.中药活性成分抑制NOD样受体蛋白3炎性小体:一种防治心力衰竭的新策略。
Front Immunol. 2025 Jan 24;16:1520482. doi: 10.3389/fimmu.2025.1520482. eCollection 2025.
4
Systematic Review of Preclinical Studies on the Efficacy and Mechanisms of Herbal Medicines in Post-Myocardial Infarction Heart Failure with Reduced Ejection Fraction.心肌梗死后射血分数降低性心力衰竭的草药疗效和作用机制的临床前研究系统评价。
Medicina (Kaunas). 2024 Jul 5;60(7):1101. doi: 10.3390/medicina60071101.
5
Effect of pueraria on left ventricular remodelling in HFrEF: A systematic review and meta-analysis.葛根对射血分数降低心衰患者左心室重构的影响:系统评价和荟萃分析。
PLoS One. 2023 Dec 4;18(12):e0295344. doi: 10.1371/journal.pone.0295344. eCollection 2023.
6
Quantitative effects of sodium-glucose cotransporter-2 inhibitors dapagliflozin and empagliflozin on quality of life in heart failure patients.钠-葡萄糖协同转运蛋白2抑制剂达格列净和恩格列净对心力衰竭患者生活质量的定量影响
Front Pharmacol. 2022 Nov 28;13:910858. doi: 10.3389/fphar.2022.910858. eCollection 2022.
7
Protective effect of traditional Chinese medicine on non-alcoholic fatty liver disease and liver cancer by targeting ferroptosis.中药通过靶向铁死亡对非酒精性脂肪性肝病和肝癌的保护作用
Front Nutr. 2022 Oct 18;9:1033129. doi: 10.3389/fnut.2022.1033129. eCollection 2022.
8
Exosomes: A novel insight into traditional Chinese medicine.外泌体:对传统中医的全新见解。
Front Pharmacol. 2022 Aug 29;13:844782. doi: 10.3389/fphar.2022.844782. eCollection 2022.

本文引用的文献

1
Salidroside attenuates cardiac dysfunction in a rat model of diabetes.红景天苷可减轻糖尿病大鼠的心脏功能障碍。
Diabet Med. 2022 Mar;39(3):e14683. doi: 10.1111/dme.14683. Epub 2021 Sep 15.
2
Tanshinone IIA protects human coronary artery endothelial cells from ferroptosis by activating the NRF2 pathway.丹参酮IIA通过激活NRF2途径保护人冠状动脉内皮细胞免受铁死亡。
Biochem Biophys Res Commun. 2021 Oct 20;575:1-7. doi: 10.1016/j.bbrc.2021.08.067. Epub 2021 Aug 24.
3
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.恩格列净治疗射血分数保留的心力衰竭。
N Engl J Med. 2021 Oct 14;385(16):1451-1461. doi: 10.1056/NEJMoa2107038. Epub 2021 Aug 27.
4
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
5
Roles and Therapeutic Implications of Endoplasmic Reticulum Stress and Oxidative Stress in Cardiovascular Diseases.内质网应激和氧化应激在心血管疾病中的作用及治疗意义
Antioxidants (Basel). 2021 Jul 22;10(8):1167. doi: 10.3390/antiox10081167.
6
Qishen Taohong Granule () as Adjuvant Therapy for Improving Cardiac Function and Quality of Life in Patients with Chronic Heart Failure: A Randomized Controlled Trial.芪参桃红颗粒()辅助治疗慢性心力衰竭患者改善心功能及生活质量的随机对照研究。
Chin J Integr Med. 2022 Jan;28(1):12-19. doi: 10.1007/s11655-021-2866-z. Epub 2021 Aug 13.
7
Hyperoside prevents sepsis-associated cardiac dysfunction through regulating cardiomyocyte viability and inflammation via inhibiting miR-21.金丝桃苷通过抑制 miR-21 调节心肌细胞活力和炎症来预防脓毒症相关性心功能障碍。
Biomed Pharmacother. 2021 Jun;138:111524. doi: 10.1016/j.biopha.2021.111524. Epub 2021 Apr 1.
8
Current and emerging drug targets in heart failure treatment.心力衰竭治疗中的现有和新兴药物靶点。
Heart Fail Rev. 2022 Jul;27(4):1119-1136. doi: 10.1007/s10741-021-10137-2. Epub 2021 Jul 17.
9
A systematic review of pharmacological activities, toxicological mechanisms and pharmacokinetic studies on Aconitum alkaloids.乌头生物碱的药理活性、毒理学机制及药代动力学研究的系统评价。
Chin J Nat Med. 2021 Jul;19(7):505-520. doi: 10.1016/S1875-5364(21)60050-X.
10
Targeting mitochondrial reactive oxygen species-mediated oxidative stress attenuates nicotine-induced cardiac remodeling and dysfunction.靶向线粒体活性氧介导的氧化应激可减轻尼古丁诱导的心脏重构和功能障碍。
Sci Rep. 2021 Jul 5;11(1):13845. doi: 10.1038/s41598-021-93234-4.

中药治疗心力衰竭的机制与疗效

Mechanisms and Efficacy of Traditional Chinese Medicine in Heart Failure.

作者信息

Wang Anzhu, Zhao Wei, Yan Kaituo, Huang Pingping, Zhang Hongwei, Zhang Zhibo, Zhang Dawu, Ma Xiaochang

机构信息

Graduate School, China Academy of Chinese Medical Sciences, Beijing, China.

Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

出版信息

Front Pharmacol. 2022 Feb 24;13:810587. doi: 10.3389/fphar.2022.810587. eCollection 2022.

DOI:10.3389/fphar.2022.810587
PMID:35281941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8908244/
Abstract

Heart failure (HF) is one of the main public health problems at present. Although some breakthroughs have been made in the treatment of HF, the mortality rate remains very high. However, we should also pay attention to improving the quality of life of patients with HF. Traditional Chinese medicine (TCM) has a long history of being used to treat HF. To demonstrate the clinical effects and mechanisms of TCM, we searched published clinical trial studies and basic studies. The search results showed that adjuvant therapy with TCM might benefit patients with HF, and its mechanism may be related to microvascular circulation, myocardial energy metabolism, oxidative stress, and inflammation.

摘要

心力衰竭(HF)是当前主要的公共卫生问题之一。尽管在HF治疗方面已取得一些突破,但死亡率仍然很高。然而,我们也应注重提高HF患者的生活质量。中医治疗HF有着悠久的历史。为了阐明中医的临床疗效及作用机制,我们检索了已发表的临床试验研究和基础研究。检索结果表明,中医辅助治疗可能使HF患者获益,其机制可能与微循环、心肌能量代谢、氧化应激及炎症有关。